CVE-2015-3956 describes a critical vulnerability in several Hospira Plum A+ and Symbiq infusion systems, allowing unauthenticated devices on the network to push unauthorized drug libraries, firmware updates, and commands. With a CVSS score of 9.8 (CRITICAL), this flaw permits complete compromise (confidentiality, integrity, availability) with low attack complexity over the network. While there is no evidence of active exploitation or public exploit code, the vulnerability has garnered significant community discussion, indicating awareness among security researchers. Hospira recommended closing FTP and TELNET ports and released a new product, Plum 360, which is not affected.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
<= 13.4CPE matchmatch criteria | cpe:2.3:o:pifzer:plum_a\+_infusion_system_firmware:*:*:*:*:*:*:*:* | ||
<= 13.6CPE matchmatch criteria | cpe:2.3:o:pifzer:plum_a\+3_infusion_system_firmware:*:*:*:*:*:*:*:* | ||
<= 3.13CPE matchmatch criteria | cpe:2.3:o:pifzer:symbiq_infusion_system_firmware:*:*:*:*:*:*:*:* |
CVSS version used by this source: 3.0
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.3 Bluesky, 0.3 Mastodon, and 2.4 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.